Michel Vounatsos | Chief Executive Officer |
Mike Hencke | Director, Investor Relations |
Al Sandrock | Executive Vice President-Research & Development |
Mike McDonnell | Chief Financial Officer |
Chirfi Guindo | EVP-Global Product Strategy & Commercialization |
Alisha Alaimo | President of U.S. Organization |
Jay Olson | Oppenheimer |
Michael Yee | Jefferies |
Umer Raffat | Evercore |
Marc Goodman | SVB Leerink |
Matthew Harrison | Morgan Stanley |
Phil Nadeau | Cowen & Company |
Paul Matteis | Stifel |
Cory Kasimov | JPMorgan |
Terence Flynn | Goldman Sachs |
Good morning. My name is Qin (ph) and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter Earnings Call and Financial Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a Question and Answer session.